Preventing Neurological Disease

Neurodyn Inc, a Canadian biotechnology company, is developing and marketing early stage, pre-clinical, diagnostic and theraputic products to treat neurodegeneration.

Neurodyn's patented pending animal model recreates neurodegeneration that occured in a group of  human patients and of pre-clinical stages of neurodegeneration.

Neurodyn to date has received direct and indirect funding in excess of $7.3 million to support the development of its model.including over $5.2 million in financial grants

Latest News

NEW Neurodyn MJFF Press Release - July 2009